PTX, another widely used chemotherapeutics was also employed for prodrug nanomedicine‐based cancer immunotherapy.[62] PTX can modulate the tumor immune microenvironment by promoting intratumoral secretion of interleukin‐10 (IL‐10), and reversing immune escape of the tumor cells by suppressing Tregs. This evidence concerns the gene IL10 and neoplasm.